ACTH (1-17) (TFA)

促肾上腺皮质激素 (1-17) (三氟乙酸)

ACTH (1-17) (TFA)

A659030-5mg

5mg

≥99%

避光,干燥,-80℃储存

超低温冰袋运输

ACTH (1-17) TFA, an adrenocorticotropin analogue, is a potent human melanocortin 1 (MC1) receptor agonist with a K i of 0.21 nM. Appearance:Solid IC50& Target:MC1R In Vitro:ACTH (1-17) TFA is a potent agonist at the hMC1R. ACTH (1-17) shows high affinity for the hMC1R with a K i value of 0.21±0.03 nM which is slightly higher than that of 0.13±0.005 nM for alpha-MSH. ACTH (1-17) induces a slight and not significant incre In Vivo:Inhibition of DNA labeling is noted when the ACTH (1-17) is administered at 2 hr after the beginning of the daily dark span when nocturnal animals become active. When administered at this circadian stage, the larger dose in particular is associated with a Biological Activity:ACTH (1-17) TFA, an adrenocorticotropin analogue, is a potent human melanocortin 1 (MC1) receptor agonist with a K i of 0.21 nM.

C95H145N29O23S.C2HF3O2

2207.43 g/mol

H2O : 100 mg/mL (45.30 mM; Need ultrasonic)